Biodesign at Fifteen

article image

Over the past decade and a half, Stanford University’s Biodesign program has evolved from an experiment to see if medtech innovation can be taught to a global influence over medical device development.

So many academic and university based medtech development programs have surfaced over the past several years that it’s easy to forget how seminal a role Stanford University’s Biodesign program has played in such efforts.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: